Cu / Mn3O4 bactericidal material as well as low-temperature preparation method and application thereof

Through the low-temperature preparation method of Cu/Mn3O4 sterilization materials, nanoCu loaded Mn3O4 is prepared by room temperature co-reduction method, which solves the problems of complex preparation process, high energy consumption and limited active sites in the existing technology, and achieves efficient killing at room temperature The effect of killing bacteria.

CN118947728APending Publication Date: 2024-11-15SHAANXI ZHONGCHUANG NAT NEW MATERIAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411033992.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing Mn3O4 composite materials have complex preparation processes, high energy consumption, and cannot mass production, and have limited active sites. They have insufficient ROS production capacity at room temperature, so they cannot quickly and effectively kill bacteria.

Method used

Using the low-temperature preparation method of Cu/Mn3O4 sterilization material, the nano-Cu-laden Mn3O4 is prepared by adding δ-MnO2 to copper acetate solution and then adding NaBH4 solution dropwise at room temperature for co-reduction to obtain nano-Cu-laden Mn3O4 to avoid high temperature treatment and reduce energy. and improve catalytic activity.

Benefits of technology

It realizes that a large amount of ROS can be generated without additional energy at room temperature, quickly and efficiently kills bacteria, and the preparation process is mild and energy consumption is low. It is suitable for industrial mass production, with low material cost, safe and environmentally friendly, and has high catalytic activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118947728A_ABST
    Figure CN118947728A_ABST
Patent Text Reader

Abstract

The invention discloses a Cu / Mn3O4 bactericidal material and a low-temperature preparation method and application thereof, and the method comprises the following steps: adding delta-MnO2 into a copper acetate solution, and carrying out ultrasonic dispersion to obtain a precursor suspension; and then dropwise adding a NaBH4 solution into the precursor suspension while stirring at room temperature, carrying out stirring reaction, washing with water, and drying to obtain the Cu / Mn3O4 bactericidal material, the loading capacity of the Cu is 1 wt.% to 5 wt.%. According to the method, strong loading and high dispersion of a nano Cu elementary substance are achieved through a co-reduction method at the room temperature, the structural stability and normal-temperature catalytic activity of the material are enhanced, formation of a large number of oxygen vacancy defects on the surface of Mn3O4 is promoted through structural reconstruction of transformation from delta-MnO2 to Mn3O4, and by means of the synergistic effect of the nano Cu elementary substance and the Mn3O4 rich in the surface defects, the catalytic activity of the material is improved. A large amount of ROS can be generated under the conditions of room temperature, weak light or no light, rapid and efficient killing of bacteria is achieved, the conditions of the whole preparation process of the method are mild, and industrial large-scale production is facilitated.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of development of room temperature catalytic sterilization materials, and relates to a Cu / Mn3O4 sterilization material and a low temperature preparation method and application thereof. Background Art

[0002] In closed and semi-closed spaces, especially in low-light / no-light and humid environments, there are a large number of bacteria. Antibacterial treatment in these special environments is difficult, and the inhalation of bacteria into the human body can not only cause respiratory diseases such as upper respiratory tract infections, asthma, and allergies, but also cause a significant increase in blood pressure in healthy people, leading to irreversible chronic lung function impairment, which seriously endangers human health. Compared with traditional antibacterial technology, room-temperature catalytic antibacterial technology does not require additional energy such as light, and has an efficient bactericidal effect by continuously releasing reactive oxygen species (ROS) at room temperature. It has the advantages of high biosafety, high stability, broad-spectrum antibacterial, long-lasting effect, and no secondary pollution.

[0003] Manganese oxides have the advantages of abundant resources, low cost, good biocompatibility, and environmental friendliness. Among them, Mn3O4 is favored in catalytic applications because of its characteristics of heterogeneous catalysis and good thermal stability. However, the catalytic performance of a single Mn3O4 still cannot meet the sterilization needs, so researchers have made many improvements to it. For example, the invention patent application with publication number CN111714636A discloses a sheet-like manganese tetraoxide sterilization material and its preparation method for photodynamic and photothermal synergistic sterilization. The sheet-like manganese tetraoxide is prepared by a hydrothermal method at 160-200°C high pressure reaction, and the indocyanine green photosensitizer is modified. Although it has a bactericidal effect, the material needs to generate a high temperature of 50°C under external laser irradiation through photodynamic and photothermal synergistic effects. The preparation method has high energy consumption and is controlled by light-driven reactions, and its practical application is limited. The invention patent application with the publication number CN116395747A discloses a manganese tetraoxide-silver sulfide Janus structure nanocomposite material and its preparation method, which is heated at 180-250°C in an inert atmosphere and requires the assistance of organic solvents such as dichloromethane, chloroform, and cyclohexane. The preparation process of this method is complicated, requires reaction at high temperature, has high Ag cost, is environmentally unfriendly, and has toxic organic solvents, etc. It is not easy to industrially mass produce, which affects its practical application. In addition, the current catalytic materials have limited active sites, limited ability to generate ROS at room temperature, and weak oxidation ability, and cannot achieve rapid and effective killing of bacteria. Summary of the invention

[0004] In view of the problems existing in the prior art, the present invention provides a Cu / Mn3O4 bactericidal material and a low-temperature preparation method and application thereof, thereby solving the technical problems in the prior art that the preparation process of Mn3O4 composite materials is complex, energy consumption is high, mass production is incapable, active sites are limited, ROS generation at room temperature is limited, oxidation ability is weak, and rapid killing of bacteria cannot be achieved.

[0005] The present invention is achieved through the following technical solutions:

[0006] A low-temperature preparation method of a Cu / Mn3O4 sterilization material comprises the following steps:

[0007] S1: Add δ-MnO2 to copper acetate solution and disperse by ultrasonic to obtain a precursor suspension;

[0008] S2: Under stirring at room temperature, NaBH4 solution is added dropwise to the precursor suspension, stirred for reaction, and then washed and dried to obtain the Cu / Mn3O4 sterilization material; the loading amount of Cu is 1wt.% to 5wt.%.

[0009] Preferably, the preparation process of the δ-MnO2 is: at room temperature, MnCl2 solution is added dropwise to KMnO4 solution, stirred for reaction, then washed with water and dried to obtain the δ-MnO2.

[0010] Preferably, the molar ratio of MnCl2 to KMnO4 is (2-5):1.

[0011] Preferably, the molar ratio of cupric acetate to delta-MnO2 is 1:(16-80).

[0012] Preferably, the concentration of the NaBH4 solution is 0.1 to 0.5 mol / L.

[0013] Preferably, the molar ratio of δ-MnO2 to NaBH4 is 1:(2-4).

[0014] Preferably, in step S2, the reaction is stirred for 60 to 120 minutes to obtain the Cu / Mn3O4 sterilization material.

[0015] Preferably, in step S2, the drying temperature is 30-60°C.

[0016] A Cu / Mn3O4 sterilization material is prepared by the above method.

[0017] The above-mentioned Cu / Mn3O4 bactericidal material is used to kill bacteria at room temperature.

[0018] Compared with the prior art, the present invention has the following beneficial technical effects:

[0019] The invention discloses a low-temperature preparation method of a Cu / Mn3O4 bactericidal material. The method first adds δ-MnO2 to a copper acetate solution, and ensures the surface adsorption of acetate, the uniform stability of δ-MnO2 in a precursor suspension, and the uniform dispersion of copper ions by ultrasonic dispersion technology. This step is a key prerequisite for forming a Cu / Mn3O4 bactericidal material because it directly affects the loading effect and dispersibility of nano Cu single substance in the subsequent reduction process. In the process, the surface carboxyl modification of δ-MnO2 is performed by the acetate after the dissolution of copper acetate through the oxygen vacancy defect on the surface of δ-MnO2 and the adsorption of acetate, so as to prepare for the subsequent combination of nano Cu and carboxyl through coordination bonds. Then, at room temperature, a NaBH4 solution is added dropwise to the precursor and stirred for reaction. As a strong reducing agent, NaBH4 simultaneously reduces copper ions and δ-MnO2 in this process, promotes the generation of nano Cu and the transformation of δ-MnO2 to Mn3O4, realizes the strong loading and high dispersion of nano Cu on the surface of Mn3O4, and avoids the energy consumption and material structure damage caused by high temperature treatment through co-reduction at room temperature. In this process, the loading amount of nano Cu is controlled between 1wt.% and 5wt.%, which not only ensures the synergistic effect of sterilization but also avoids the excessive size of Cu particles caused by agglomeration, which affects the sterilization effect, and at the same time ensures the presence of a large number of oxygen vacancy defects on the surface of Mn3O4, thereby improving the catalytic sterilization performance at room temperature. The high dispersion and strong loading of nano Cu on Mn3O4 rich in surface defects can promote electron transfer, thereby accelerating the rate of catalytic reaction at room temperature, exerting the synergistic effect of nano Cu and a large number of defect sites on the surface of Mn3O4, and promoting the production of a large number of reactive oxygen species (ROS) at room temperature, weak light conditions, or even no light conditions, thereby effectively killing bacteria. That is, the method of the present invention is based on δ-MnO2 and copper acetate, and under the action of sodium borohydride, Mn3O4 loaded with nano Cu is prepared by co-reduction at room temperature, without high temperature treatment, reducing energy consumption and environmental pollution, realizing strong loading and high dispersion of nano Cu single substance by co-reduction method, enhancing the structural stability and catalytic activity of the material, and promoting the formation of a large number of oxygen vacancy defects on the surface of Mn3O4 by structural reconstruction of δ-MnO2 to Mn3O4, utilizing the synergistic effect of nano Cu single substance and Mn3O4 rich in surface defects, without any additional energy, generating a large number of ROS by catalysis at room temperature under weak light or no light conditions, realizing rapid and efficient killing of bacteria, and preparing the whole process under mild conditions, low energy consumption, and conducive to industrial amplification production. In addition, only aqueous solution is used in the synthesis method, without introducing any organic / toxic solvent, the preparation method is simple and convenient, the synthesis equipment requirements are low, and the obtained Cu / Mn3O4 bactericidal material has low cost, safety and environmental protection, high stability, high catalytic activity and good biocompatibility.

[0020] Furthermore, the preparation process of the δ-MnO2 is as follows: at room temperature, the MnCl2 solution is added dropwise to the KMnO4 solution, stirred for reaction, and then washed and dried to obtain the δ-MnO2. By adding the MnCl2 solution dropwise to the KMnO4 solution, the crystal nucleation growth process can be controlled at a relatively low temperature at room temperature to ensure the generation of low-crystallinity δ-MnO2, thereby promoting the formation of surface oxygen vacancy defects. The surface oxygen vacancy defects of δ-MnO2 are conducive to the subsequent surface carboxyl modification and the promotion of defective Mn3O4 generation, which is the basis for ensuring efficient Cu / Mn3O4 sterilization materials. This process does not require extreme conditions such as high temperature and high pressure, which not only reduces energy consumption, but also reduces the risk of damage to the surface defect structure caused by high temperature. At the same time, the mild reaction conditions also make the low-temperature preparation method more environmentally friendly and safe.

[0021] Furthermore, the molar ratio of MnCl2 to KMnO4 is (2-5):1, which is slightly higher than the molar ratio of the theoretical reaction. By precisely controlling the molar ratio of MnCl2 to KMnO4, the high-Mn valence oxidant KMnO4 reacts with an appropriate excess of the low-Mn valence reductant MnCl2, promoting the formation of more low-Mn (Mn 2+ and Mn 3+ ) is formed, thereby promoting the generation of surface oxygen vacancy defects. At the same time, this ratio can affect the reaction process and the product crystal phase. This ratio is more conducive to the formation and stable existence of the specific crystalline phase of δ-MnO2. In the subsequent preparation of Cu / Mn3O4 bactericidal materials, δ-MnO2 is used as a precursor. Its chemical structure and surface composition directly affect the synthesis process and catalytic performance of Cu / Mn3O4. The optimized δ-MnO2 can promote the formation of more active sites on the surface of Mn3O4 and ensure the subsequent carboxyl modification to firmly bond nano-Cu, thereby enhancing the bactericidal effect and stability of Cu / Mn3O4.

[0022] Furthermore, the molar ratio of cupric acetate to δ-MnO2 is 1:(16-80). By adjusting this ratio, on the one hand, the ratio can meet the demand for carboxyl surface modification, control the appropriate carboxyl group and the subsequent nano-Cu coordination bonding to ensure the firm chemical bonding between Cu and Mn3O4, and retain a certain amount of oxygen vacancy defects on the surface of δ-MnO2 to promote the formation of surface defects of Mn3O4. On the other hand, the ratio can control the loading amount of nano-Cu element on Mn3O4. The loading amount is one of the key factors affecting the catalytic activity and bactericidal performance of the bactericidal material. The appropriate loading amount helps to achieve the optimal synergistic effect between nano-Cu element and oxygen vacancy defect sites on the surface of Mn3O4, thereby ensuring the generation of more ROS at room temperature and improving the bactericidal efficiency.

[0023] Further, the concentration of the NaBH4 solution is 0.1-0.5 mol / L. As a strong reducing agent, NaBH4 can ensure a suitable reduction rate within this concentration range, promote the coordination bonding of nano Cu single substance with the surface carboxyl group of Mn3O4, ensure the high dispersion and strong load of nano Cu single substance on Mn3O4, thereby enhancing the catalytic activity and bactericidal effect of the material. In addition, due to the difference in the reduction potential of copper ions and δ-MnO2, the reduction order is slightly different during the co-reduction reaction. The appropriately high concentration of NaBH4 can ensure the synchronous reduction of copper ions and δ-MnO2 as much as possible, so that nano Cu single substance and Mn3O4 are basically generated synchronously, which is conducive to promoting the loading of nano Cu single substance on the surface of Mn3O4 and the firm bonding of nano Cu and Mn3O4, ensuring the high exposure of nano Cu single substance and exerting a synergistic catalytic effect, and ensuring the structural stability of Cu / Mn3O4, thereby improving the room temperature catalytic activity of Cu / Mn3O4 bactericidal materials.

[0024] Furthermore, the molar ratio of δ-MnO2 to NaBH4 is 1:(2-4), and the amount of NaBH4 used directly affects the chemical reaction process and rate of reduction, so that the reaction is carried out under mild and controllable conditions. This ratio control can regulate the degree of reduction reaction, and can ensure that copper ions and δ-MnO2 are fully reduced and nano Cu and Mn3O4 are generated. A large number of defects are easily formed during the structural reconstruction process of δ-MnO2 to Mn3O4. At the same time, an appropriate excess of NaBH4 promotes the reduction of low-valent Mn (Mn 2+ and Mn 3+ ) in Mn3O4, further promoting the formation of more surface oxygen vacancy defects and generating more active sites to promote the catalytic production of more ROS at room temperature.

[0025] Further, in step S2, the reaction is stirred at room temperature for 60 to 120 minutes to obtain the Cu / Mn3O4 bactericidal material. Stirring can enhance the mass transfer process in the solution, accelerate the chemical reaction rate, shorten the reaction time and increase the yield, thereby ensuring that the precursor suspension and NaBH4 react fully and quickly. Air is easily introduced during liquid stirring to promote the formation of pore structure in the material and increase the specific surface area, which is beneficial to the bacterial adsorption in the first step of the catalytic reaction sterilization process. Stirring also helps to uniformly disperse nano Cu particles and reduce particle agglomeration. This high dispersibility makes the Cu / Mn3O4 bactericidal material have higher catalytic activity, thereby enhancing its bactericidal performance. During the stirring reaction, the reaction time of 60 to 120 minutes at room temperature not only ensures the full reduction of copper ions and δ-MnO2 to form a stable nano Cu element-loaded Mn3O4 structure rich in surface oxygen vacancy defects, but also avoids the problem of excessive particle size caused by excessive particle agglomeration and excessive crystal growth, which affects the material performance. The Cu / Mn3O4 bactericidal material obtained by stirring at room temperature and controlling the appropriate reaction time is more stable in structure and performance, which is conducive to meeting the requirements for long-term effectiveness and stability of the material in practical applications.

[0026] Furthermore, in step S2, the drying temperature is 30-60°C. Within this temperature range, the material can be effectively dried, while avoiding the destruction of the oxygen vacancy defect structure on the surface of Mn3O4 and the agglomeration of nano Cu particles that may be caused by high temperature. The defect-rich Mn3O4 and the loaded nano Cu element can maintain good stability within this temperature range. Too high a drying temperature will lead to a reduction in the oxygen vacancy defect active sites on the surface of Mn3O4, reducing its catalytic activity, while a drying temperature of 30-60°C can better maintain the surface active sites, maintain the stability and consistency of the material, thereby ensuring its excellent bactericidal performance. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0028] Figure 1 It is a schematic flow chart of a low-temperature preparation method of a Cu / Mn3O4 sterilization material in the present invention;

[0029] Figure 2 XRD spectra of δ-MnO2 and Cu / Mn3O4 bactericidal materials prepared in the present invention;

[0030] Figure 3The results of the bactericidal test of the material prepared in the present invention on Gram-negative bacteria (G-), wherein the bacteria species is Escherichia coli, (a) is the control group, (b) is the δ-MnO2 experimental group, (c) is the Cu / Mn3O4 experimental group of Example 1, and (d) is the Cu / Mn3O4 experimental group of Example 2;

[0031] Figure 4 The results of the bactericidal test of the material prepared in the invention on Gram-positive bacteria (G+), wherein the bacteria species is Staphylococcus aureus, (a) is the control group, (b) δ-MnO2 is the experimental group, (c) is the Cu / Mn3O4 experimental group of Example 1, and (d) is the Cu / Mn3O4 experimental group of Example 2. DETAILED DESCRIPTION

[0032] In order to enable those skilled in the art to understand the characteristics and effects of the present invention, the following is a general description and definition of the terms and expressions mentioned in the specification and claims. Unless otherwise specified, all technical and scientific terms used in the text are the common meanings understood by those skilled in the art for the present invention. In the event of a conflict, the definition in this specification shall prevail.

[0033] The theories or mechanisms described and disclosed herein, whether correct or incorrect, should not limit the scope of the present invention in any way, that is, the present invention can be implemented without being limited by any specific theory or mechanism.

[0034] Herein, all features such as values, quantities, contents and concentrations defined in the form of numerical ranges or percentage ranges are for simplicity and convenience only. Accordingly, the description of numerical ranges or percentage ranges should be considered to have included and specifically disclosed all possible secondary ranges and individual values ​​within the range (including integers and fractions).

[0035] In this document, unless otherwise specified, “includes,” “including,” “contains,” “has,” or similar terms cover the meanings of “consisting of” and “mainly consisting of,” for example, “A includes a” covers the meanings of “A includes a and other” and “A only includes a.”

[0036] In this document, in order to make the description concise, not all possible combinations of various technical features in various embodiments or examples are described. Therefore, as long as there is no contradiction in the combination of these technical features, the various technical features in various embodiments or examples can be combined arbitrarily, and all possible combinations should be considered to be within the scope of this specification.

[0037] like Figure 1 As shown, the present invention provides a low-temperature preparation method of a Cu / Mn3O4 sterilization material, comprising the following steps:

[0038] S1: Add δ-MnO2 to copper acetate solution and disperse by ultrasonic to obtain a precursor suspension;

[0039] The preparation process of the δ-MnO2 is as follows: at room temperature, a MnCl2 solution is added dropwise to a KMnO4 solution, stirred for reaction, and then washed and dried to obtain the δ-MnO2. The δ-MnO2 obtained by this method has a low crystallinity and oxygen vacancy defects, which is conducive to the subsequent surface modification of carboxyl groups and the promotion of the generation of defective Mn3O4.

[0040] In a specific preparation method, the preparation process of δ-MnO2 is as follows: 0.5g KMnO4 is dissolved in 30mL H2O, 1g MnCl2 is dissolved in 45mL water, and the MnCl2 solution is added dropwise to the KMnO4 solution under stirring at room temperature, reacted for 1h, washed with water, and dried at 60°C to obtain δ-MnO2 powder.

[0041] The molar ratio of MnCl2 to KMnO4 is (2-5): 1. The molar ratio of cupric acetate to delta-MnO2 is 1: (16-80). The cupric acetate solution is a cupric acetate aqueous solution.

[0042] S2: Under stirring at room temperature, NaBH4 solution is added dropwise to the precursor suspension, and after stirring for 60 to 120 minutes, the mixture is washed with water and dried at 30 to 60°C to obtain the Cu / Mn3O4 bactericidal material; the Cu loading is 1 wt.% to 5 wt.%.

[0043] The concentration of the NaBH4 solution is 0.1-0.5 mol / L. The molar ratio of δ-MnO2 to NaBH4 is 1:(2-4). The NaBH4 solution is a NaBH4 aqueous solution.

[0044] At the same time, the invention also discloses the application of the above-mentioned Cu / Mn3O4 bactericidal material in killing bacteria at room temperature.

[0045] The test method for the sterilization effect of the material in the present invention is to test the sterilization efficiency by plate counting method, and the bacteria are Escherichia coli and Staphylococcus aureus. Test conditions: no light or dark conditions, room temperature, bacterial density of 1.0×10 6 ~1.0×10 8 CFU / mL.

[0046] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.

[0047] The following examples use conventional instruments and equipment in the art. The experimental methods in the following examples where specific conditions are not specified are usually carried out under conventional conditions or under conditions recommended by the manufacturer. The various raw materials used in the following examples are conventional commercial products unless otherwise specified, and their specifications are conventional specifications in the art. In the specification of the present invention and the following examples, unless otherwise specified, "%" means weight percentage, "part" means weight part, and ratio means weight ratio.

[0048] Example 1

[0049] δ-MnO2 powder was added to an aqueous solution of copper acetate, and ultrasonically dispersed for 2 hours to obtain a precursor suspension; 0.1 mol / L NaBH4 aqueous solution was added to the precursor suspension under stirring at room temperature, stirred for 60 minutes, washed with water, and dried at 60°C to obtain a Cu / Mn3O4 room temperature catalytic sterilization material. The molar ratio of copper acetate to δ-MnO2 was 1:80, the molar ratio of δ-MnO2 to NaBH4 was 1:4, and the Cu loading was 5wt.%.

[0050] Example 2

[0051] δ-MnO2 powder was added to an aqueous solution of copper acetate, and ultrasonically dispersed for 5 hours to obtain a precursor suspension; 0.4 mol / L NaBH4 aqueous solution was added to the precursor suspension under stirring at room temperature, stirred for 120 minutes, washed with water, and dried at 40°C to obtain a Cu / Mn3O4 room temperature catalytic sterilization material. The molar ratio of copper acetate to δ-MnO2 was 1:16, the molar ratio of δ-MnO2 to NaBH4 was 1:2, and the Cu loading was 1wt.%.

[0052] Example 3

[0053] δ-MnO2 powder was added to an aqueous solution of copper acetate, and ultrasonically dispersed for 2 hours to obtain a precursor suspension; 0.3 mol / L NaBH4 aqueous solution was added to the precursor suspension under stirring at room temperature, stirred for 80 minutes, washed with water, and dried at 60°C to obtain a Cu / Mn3O4 room temperature catalytic sterilization material. The molar ratio of copper acetate to δ-MnO2 was 1:25, the molar ratio of δ-MnO2 to NaBH4 was 1:3, and the Cu loading was 2wt.%.

[0054] Example 4

[0055] δ-MnO2 powder was added to an aqueous solution of copper acetate, and ultrasonically dispersed for 3 hours to obtain a precursor suspension; 0.2 mol / L NaBH4 aqueous solution was added to the precursor suspension under stirring at room temperature, stirred for 100 minutes, washed with water, and dried at 50°C to obtain a Cu / Mn3O4 room temperature catalytic sterilization material. The molar ratio of copper acetate to δ-MnO2 was 1:50, the molar ratio of δ-MnO2 to NaBH4 was 1:2.5, and the Cu loading was 4wt.%.

[0056] Example 5

[0057] δ-MnO2 powder was added to an aqueous solution of copper acetate, and ultrasonically dispersed for 6 hours to obtain a precursor suspension; 0.5 mol / L NaBH4 aqueous solution was added to the precursor suspension under stirring at room temperature, stirred for 90 minutes, washed, and dried at 30°C to obtain a Cu / Mn3O4 room temperature catalytic sterilization material. The molar ratio of copper acetate to δ-MnO2 was 1:65, the molar ratio of δ-MnO2 to NaBH4 was 1:3.5, and the loading amount of Cu was 3wt.%.

[0058] Figure 2 The XRD spectra of the δ-MnO2 and Cu / Mn3O4 sterilization materials prepared in the present invention show that the characteristic diffraction peak of Mn3O4 appears in Cu / Mn3O4, corresponding to the standard card PDF 16-0154, indicating that δ-MnO2 is transformed into Mn3O4. The characteristic diffraction peak of Cu is not detected due to the low content of nano Cu element and high dispersion.

[0059] Figure 3 The results of the bactericidal test of the material prepared in the present invention against Gram-negative bacteria (G-) are shown in FIG. Figure 4 The results of the bactericidal test of the material prepared in the invention against Gram-positive bacteria (G+), wherein: Figure 3 and Figure 4 The corresponding bacteria are Escherichia coli and Staphylococcus aureus, respectively. (a) is the control group, (b) is the δ-MnO2 experimental group, (c) is the Cu / Mn3O4 experimental group of Example 1, and (d) is the Cu / Mn3O4 experimental group of Example 2. It can be seen from the figure that the bactericidal efficiency of δ-MnO2 on Escherichia coli and Staphylococcus aureus is 12.18% and 9.29%, respectively, and the bactericidal effect is poor. The room-temperature catalytic bactericidal efficiency of Cu / Mn3O4 prepared in Example 1 on Escherichia coli and Staphylococcus aureus is 99.99%, and the room-temperature catalytic bactericidal efficiency of Cu / Mn3O4 in Example 2 on Escherichia coli and Staphylococcus aureus is 99.99%. Therefore, the Cu / Mn3O4 bactericidal material prepared by the present invention has high-efficiency bactericidal performance.

[0060] Example 6

[0061] A low-temperature preparation method of a Cu / Mn3O4 sterilization material comprises the following steps:

[0062] S1: adding δ-MnO2 to a copper acetate solution, and dispersing by ultrasonication to obtain a precursor suspension; wherein the molar ratio of MnCl2 to KMnO4 is 2:1, and the molar ratio of copper acetate to δ-MnO2 is 1:16;

[0063] S2: Under stirring at room temperature, add a 0.1 mol / L NaBH4 solution to the precursor suspension, wherein the molar ratio of δ-MnO2 to NaBH4 is 1:2, stir and react for 60 minutes, then wash and dry to obtain the Cu / Mn3O4 sterilization material.

[0064] Example 7

[0065] A low-temperature preparation method of a Cu / Mn3O4 sterilization material comprises the following steps:

[0066] S1: adding δ-MnO2 to a copper acetate solution, and dispersing by ultrasonication to obtain a precursor suspension; wherein the molar ratio of MnCl2 to KMnO4 is 5:1, and the molar ratio of copper acetate to δ-MnO2 is 1:80;

[0067] S2: Under stirring at room temperature, add a 0.5 mol / L NaBH4 solution to the precursor suspension, wherein the molar ratio of δ-MnO2 to NaBH4 is 1:4, stir and react for 120 minutes, then wash and dry to obtain the Cu / Mn3O4 sterilization material.

[0068] Example 8

[0069] A low-temperature preparation method of a Cu / Mn3O4 sterilization material comprises the following steps:

[0070] S1: adding δ-MnO2 to a copper acetate solution, and dispersing by ultrasonication to obtain a precursor suspension; wherein the molar ratio of MnCl2 to KMnO4 is 3:1, and the molar ratio of copper acetate to δ-MnO2 is 1:50;

[0071] S2: Under stirring at room temperature, add a 0.3 mol / L NaBH4 solution to the precursor suspension, wherein the molar ratio of δ-MnO2 to NaBH4 is 1:3. After stirring for 90 minutes, wash with water and dry to obtain the Cu / Mn3O4 sterilization material.

[0072] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

[0073] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the scope of protection of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.

Claims

1. A low temperature preparation method of Cu / Mn3O4 sterilization material, characterized in that: The following steps are involved: S1: Add δ-MnO2 to copper acetate solution and disperse by ultrasonic to obtain a precursor suspension; S2: Under stirring at room temperature, NaBH4 solution is added dropwise to the precursor suspension, stirred for reaction, and then washed and dried to obtain the Cu / Mn3O4 sterilization material; the loading amount of Cu is 1wt.% to 5wt.%.

2. The low-temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: The preparation process of the δ-MnO2 is as follows: at room temperature, a MnCl2 solution is added dropwise to a KMnO4 solution, stirred for reaction, and then washed with water and dried to obtain the δ-MnO2.

3. The low temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 2, characterized in that: The molar ratio of MnCl2 to KMnO4 is (2-5):

1.

4. The low-temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: The molar ratio of the cupric acetate to delta-MnO2 is 1:(16-80).

5. The low-temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: The concentration of the NaBH4 solution is 0.1-0.5 mol / L.

6. The low temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: The molar ratio of δ-MnO2 to NaBH4 is 1:(2-4).

7. The low-temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: In step S2, the reaction is stirred for 60 to 120 minutes to obtain the Cu / Mn3O4 sterilization material.

8. The low-temperature preparation method of a Cu / Mn3O4 bactericidal material according to claim 1, characterized in that: In step S2, the drying temperature is 30-60°C.

9. A Cu / Mn3O4 sterilization material, characterized in that: It is prepared by the method according to any one of claims 1 to 8.

10. Use of the Cu / Mn3O4 bactericidal material as claimed in claim 9 in killing bacteria at room temperature.